Kevin Klug – FDA Warning Letter, Jul 3, 2019
On June 10 and July 3, 2019, the FDA investigated Mr. Kevin J. Klug's dairy operation in Wynot, Nebraska, identifying violations of the Federal Food, Drug, and Cosmetic Act.
A cow sold for slaughter on January 3, 2019, was found to be adulterated. USDA/FSIS analysis revealed Desfuroylceftiofur at 1.216 ppm in kidney tissue, exceeding the FDA tolerance of 0.4 ppm (21 C.F.R. § 556.113(b)(3)(i)), rendering the food adulterated under section 402(a)(2)(C)(ii) of the FD&C Act.
Additionally, the new animal drug Ceftiofur Crystalline Free Acid was adulterated. Mr. Klug administered the drug extralabelly, violating 21 C.F.R. Part 530. Specifically, the cow received a second dose on December 20, 2018, instead of 72 hours after the initial December 13, 2018 dose. The dose was based on an estimated 1200 lbs, but the cow weighed 850 lbs, resulting in an overdose. The drug was administered on the side of the tailhead, not the approved subcutaneous ear injection site. This extralabel
ID · 5b9fbd39-76de-4a24-a020-58d8abdb522a
Full citation text and observation details available on the Dashboard.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.